abstract |
The present invention provide a kind of for determine experimenter whether have maybe will development laryngeal carcinoma mark, comprising: creatine, 1, one or more in 3 diaminopropanes, thymus pyrimidine, 3 aminoisobutyric acids, cytidylic acid and putrescine, diagnostic sensitivity is up to 93.33%, and specificity is 0%. |